Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action

Circulation

Volumn 100, Issue 7, 1999, Pages 690-692

  Tomomi, Ide ^a   Tsutsui, Hiroyuki ^a   Kinugawa, Shintaro ^a   Utsumi, Hideo ^b   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Antiarrhythmia agents; Free radicals; Myocytes; Spectroscopy

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIOXIDANT; ATENOLOL; DISOPYRAMIDE; FREE RADICAL; HYDROXYL RADICAL; SCAVENGER;

ARTICLE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOG; DRUG MECHANISM; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; HUMAN CELL; ISCHEMIC HEART DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0344564153     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.100.7.690     Document Type: Article

References (18)

1. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N Engl J Med. 1995;333:77-82.
2. Massie BM, Fisher SG, Radford M, Deedwania PC, Singh BN, Fletcher RD, Singh SN. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. Circulation. 1996;93: 2128-2134.
3. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Effect of encainide and flecainide on mortality in infarction. N Engl J Med. 1989;321:406-412.
4. Waldo AL, Camm AJ, deRuyter H, Friedman PL, MacNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP, The SWORD Investigators. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet. 1996; 348:7-12.
5. Stevenson WG. Mechanisms and management of arrhythmias in heart failure. Curr Opin Cardiol. 1995;10:274-281.
6. Bolli R. Mechanism of myocardial "stunning." Circulation. 1990;82: 723-738.
7. Belch JJ, Bridges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J. 1991;65:245-248.
8. Mallat Z, Philip I, Lebret M, Chatel D, Maclouf J, Tedgui A. Elevated levels of 8-iso-prostaglandin F2α in pericardial fluid of patients with heart failure. A potential role for in vivo oxidant stress in ventricular dilatation progression to heart failure. Circulation. 1998;97:1536-1539.
9. Josephson RA, Silverman HS, Lakatta EG, Stern MD, Zweier JL. Study of the mechanisms of hydrogen peroxide and hydroxyl free radical-induced cellular injury and calcium overload in cardiac myocytes. J Biol Chem. 1991;266:2354-2361.
10. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
11. Yue TL, Cheng HY, Lysko PG, McKenna PJ, Feuerstein R, Gu JL, Lysko KA, Davis LL, Feuerstein G. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. J Pharm Exp Ther. 1992;263:92-98.
12. Ribeiro SM, Campello AP, Nascimento AJ, Kluppel ML. Effect of amiodarone (AMD) on the antioxidant enzymes, lipid peroxidation and mitochondrial metabolism. Cell Biochem Funct. 1997;15:145-152.
13. Mak I, Arroyo C, Weglicki W. Inhibition of sarcolemmal carbon-centered free radical formation by propranolol. Circ Res. 1989;65:1151-1156.
14. 2+-ATPaSe in contractile dysfunction of myocytes in tachycardia-induced heart failure. Am J Physiol. 1998;275:H31-H40.
15. Heger JJ, Prystowsky EN, Zipes DP. Relationship between amiodarone dosage, drug concentrations and adverse side effects. Am Heart J. 1983; 106:931-935.
16. Jendrasiak GL, McIntosh TJ, Ribeiro A, Porter RS. Amiodaroneliposome interaction: a multi-nuclear NMR and X-ray diffraction study. Biochim Biophys Acta. 1990;1024:19-31.
17. Trumbore M, Chester DW, Moring J, Rhodes D, Herbette LG. Structure and location of amiodarone in a membrane bilayer as determined by molecular mechanics and quantitative x-ray diffraction. Biophys J. 1988; 54:535-543.
18. Dhalla AK, Hill MF, Singal PK. Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol. 1996;28:506-514.